PML Lawsuit News and Information
Rituxan Lawsuit
Side effects of Ritxan may result in the development of a rare, but often-fatal brain infection known as progressive multifocal leukoencephalopathy (PML). At least 57 Rituxan PML brain infection cases have been reported, with a 90% fatality rate.
All Articles Tagged With: "PML"
Kidney Transplant Drugs Receive New Warnings About Infection Side Effects
The FDA is requiring new warnings on several immunosuppressant drugs designed to prevent renal transplant patients from rejecting new kidneys. The new labeling will warn users of potential side effects that may increase the risk of infections due to a suppressed immune system.
Tysabri Side Effects Linked to 9th PML Infection Case
A new case of a rare, often lethal, brain infection has been linked to the multiple sclerosis drug Tysabri, making it the ninth case of progressive multifocal leukoencephalopathy (PML) infection potentially caused by side effects of Tysabri since the drug was put back on the market in July 2006.
Rituxan Fatal Infections Lead FDA to Review Risk of Side Effects
Following reports that link side effects of Rituxan to fatal brain infections, the FDA is reviewing whether users of the cancer-fighting drug should use the medication for shorter periods of time or take “drug holidays” to reduce the risk.
Rituxan PML Brain Infections Reported in 57 People
A new study indicates that at least 57 patients being treated with the lymphoma-fighting drug Rituxan have developed a rare brain infection, known as progressive multifocal leukoencephalitis (PML), and the cases have involved a 90% fatality rate.
Tysabri Brain Infection Reported in another Multiple-Sclerosis Patient
According to a report in the Wall Street Journal, another multiple sclerosis patient has developed a rare and often fatal brain infection, known as progressive multifocal leukoencephalopathy, or PML, as a possible side effect of Tysabri.
Raptiva Infection Lawsuit Filed in California After Recall
A complaint was filed last week in California on behalf of a three psoriasis patients who allegedly suffered serious side effects of Raptiva. The lawsuit was filed on April 9, 2009, the day after Genentech announced that they were issuing a Raptiva recall in the United States due to an increased risk of infections [...]
Raptiva Infection Side Effects Lead to Recall in U.S.
Genentech, Inc. has issued a Raptiva recall in the United States as a result of side effects which could cause a rare, but often fatal, brain infection that attacks the central nervous system, known as progressive multifocal leukoencephalopathy (PML).
Raptiva Recall in Canada and Europe Due to Risk of PML Brain Infection
Following recommendations that a Raptiva recall be issued due to a potential risk of users developing a deadly brain infection, sales of the psoriasis drug are being suspended in Canada and Europe. In the United States, the FDA is continuing to review whether the benefits of Raptiva outweigh the risks, and have urged doctors [...]
Raptiva PML Infection Warning Issued in Canada after Two Deaths in U.S.
Health Canada has released a letter sent to healthcare providers warning about an increased risk of serious infections, including Progressive Multifocal Leukoencephalopathy (PML), as a side effect of Raptiva. They disclosed that two deaths from PML have been reported in the United States among patients taking Raptiva for psoriasis.
Contact a Lawyer
Submit information about your potential case to be reviewed by an attorney.
